OSCR

TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease.

Overview

Authors: Yanhao Zhao1, Zimeng Huang1, Jianing Gao1, Aolan Li2, Huizhi Wang1, Yingchuan Chen2, Guanyu Zhu2, Xin Zhang1, Yin Jiang1, Moxuan Zhang3, Fangang Meng1,2, Jianguo Zhang1,2, Tingting Du1
  1. Department of Functional Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
  2. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  3. Department of Neurosurgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
Dates: received 11 February 2026; accepted 7 August 2026; published online 17 August 2026; in print August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1002/advs.77175 · PMID 42606072 · PMCID PMC13479592 · OpenAlex W7203641397
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: Parkinson's (population), cellular / molecular (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Machine learning, Connectivity, Spectral & time-frequency
Keywords: lumacaftor, neuroinflammation, parkinson's disease, TAB2
Topic: Parkinson's Disease Mechanisms and Treatments (Neurology, Medicine), according to OpenAlex
Funding: Beijing Natural Science Foundation Support Project (7254306); National Natural Science Foundation of China (82101514); Beijing High-level Innovative and Entrepreneurial Talent Support Program (G202512038); Beijing Neurosurgical Institute Major Frontier Science and Technology Fund (5)
Citations: not cited yet (Europe PMC); 56 references in the paper

Abstract

Neuroinflammation plays a key role in exacerbating dopaminergic neuron loss in Parkinson's disease (PD). We identified TAB2 as an early‐stage biomarker, which was elevated in PD patients’ microglia. However, the role of TAB2 in the pathogenesis of PD remains unknown. In this study, we found that Tab2 knockdown inhibited the activation of microglia and protected neurons in PD models. STAT3, as a transcription factor for TAB2, regulated TAB2 expression. Mechanistically, TAB2 interacted with α‐synuclein and facilitated the recognition of K63‐linked ubiquitin chains, leading to the formation of the TAK1–TABs complex and activation of TAK1, which was ultimately followed by activation of the nuclear factor‐kappa B (NF‐κB) signaling pathway. Furthermore, microglia‐specific knockdown of Tab2 significantly inhibited microglia activation, protected dopaminergic neurons, improved motor function, and attenuated anxiety‐like behaviors in PD mouse model. We further showed that the FDA‐approved drug, lumacaftor, suppressed microglial TAB2 expression and had potent anti‐inflammatory and neuroprotective effects in PD models. Taken together, our study reveals that the STAT3–TAB2–NF‐κB–IL‐1β positive feedback axis in microglia is a crucial checkpoint that exacerbates neuroinflammation in PD. Therefore, these findings identify a pivotal role of TAB2 in regulating microglia‐mediated neuroinflammation, suggesting that targeting TAB2 may be a possible therapeutic strategy for PD.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The data that support the findings of this study are openly available in ModelArchive at https://modelarchive.org, reference number 10.5452/ma‐tab2‐pd.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, pages, dates, 13 authors, 4 keywords, 4 funders, 56 references.

Cite

This paper

Zhao, Y., Huang, Z., Gao, J., Li, A., Wang, H., Chen, Y., Zhu, G., Zhang, X., Jiang, Y., Zhang, M., Meng, F., Zhang, J., & Du, T. (2026). TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease. Advanced science (Weinheim, Baden-Wurttemberg, Germany), e77175. https://doi.org/10.1002/advs.77175

BibTeX

@article{zhao2026tab2,
author = {Zhao, Yanhao and Huang, Zimeng and Gao, Jianing and Li, Aolan and Wang, Huizhi and Chen, Yingchuan and Zhu, Guanyu and Zhang, Xin and Jiang, Yin and Zhang, Moxuan and Meng, Fangang and Zhang, Jianguo and Du, Tingting},
title = {{TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease}},
journal = {Advanced science (Weinheim, Baden-Wurttemberg, Germany)},
year = {2026},
month = aug,
pages = {e77175},
publisher = {Wiley},
issn = {2198-3844},
doi = {10.1002/advs.77175},
url = {https://doi.org/10.1002/advs.77175},
pmid = {42606072},
pmcid = {PMC13479592}
}

RIS

TY - JOUR
AU - Zhao, Yanhao
AU - Huang, Zimeng
AU - Gao, Jianing
AU - Li, Aolan
AU - Wang, Huizhi
AU - Chen, Yingchuan
AU - Zhu, Guanyu
AU - Zhang, Xin
AU - Jiang, Yin
AU - Zhang, Moxuan
AU - Meng, Fangang
AU - Zhang, Jianguo
AU - Du, Tingting
TI - TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease
T2 - Advanced science (Weinheim, Baden-Wurttemberg, Germany)
J2 - Adv Sci (Weinh)
PY - 2026
DA - 2026/08/17
SP - e77175
SN - 2198-3844
PB - Wiley
DO - 10.1002/advs.77175
UR - https://doi.org/10.1002/advs.77175
LA - en
ER -

CSL-JSON

{
"id": "10.1002/advs.77175",
"type": "article-journal",
"title": "TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease",
"container-title": "Advanced science (Weinheim, Baden-Wurttemberg, Germany)",
"author": [
{
"family": "Zhao",
"given": "Yanhao"
},
{
"family": "Huang",
"given": "Zimeng"
},
{
"family": "Gao",
"given": "Jianing"
},
{
"family": "Li",
"given": "Aolan"
},
{
"family": "Wang",
"given": "Huizhi"
},
{
"family": "Chen",
"given": "Yingchuan"
},
{
"family": "Zhu",
"given": "Guanyu"
},
{
"family": "Zhang",
"given": "Xin"
},
{
"family": "Jiang",
"given": "Yin"
},
{
"family": "Zhang",
"given": "Moxuan"
},
{
"family": "Meng",
"given": "Fangang"
},
{
"family": "Zhang",
"given": "Jianguo"
},
{
"family": "Du",
"given": "Tingting"
}
],
"container-title-short": "Adv Sci (Weinh)",
"page": "e77175",
"DOI": "10.1002/advs.77175",
"PMID": "42606072",
"PMCID": "PMC13479592",
"ISSN": "2198-3844",
"publisher": "Wiley",
"URL": "https://doi.org/10.1002/advs.77175",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
17
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1002/ame2.70252
Single-cell atlas of neuroglial dynamics in SNCA-A53T Parkinson's disease mouse model.
Journal: Animal models and experimental medicine
In common: NCBI GEO GSE157783, Parkinson's, cellular / molecular, 2 references
[2] doi:10.3389/fnins.2026.1862571
Integrated bulk, single-cell, and spatial transcriptomic analyses prioritize NOTCH1 as a candidate gene associated with neurovascular and immune-related alterations in Parkinson's disease.
Journal: Frontiers in neuroscience
In common: Parkinson's, cellular / molecular, 4 references
[3] doi:10.1038/s41467-026-71317-y [code]
TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation.
Journal: Nature communications
In common: Parkinson's, cellular / molecular, 4 references
[4] doi:10.1038/s44321-026-00473-x
OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation.
Journal: EMBO molecular medicine
In common: cellular / molecular, 3 references
[5] doi:10.1101/gr.281113.125 [code]
Single-nucleus multiomic profiling of the aging mouse substantia nigra reveals conserved gene alterations linked to Parkinson's disease.
Journal: Genome research
In common: Parkinson's, cellular / molecular, 3 references
[6] doi:10.3390/ijms27167140
Astrocytic HSP90AA1 Upregulation and Altered Synaptic Signaling in Parkinson's Disease: Transcriptomic Screening and In Vivo Validation.
Journal: International journal of molecular sciences
In common: Parkinson's, cellular / molecular, 3 references
[7] doi:10.1038/s41597-026-07185-4 [code]
A multi-center cross-platform single-cell multimodal atlas of the mouse cerebral cortex.
Journal: Scientific data
In common: 4 references
[8] doi:10.1155/padi/8731032
Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson's Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning.
Journal: Parkinson's disease
In common: Parkinson's, cellular / molecular, 2 references
[9] doi:10.1038/s41380-026-03667-4
Engineering functional ventral midbrain dopaminergic neurons in human organoids through WNT modulation and bioreactor culture.
Journal: Molecular psychiatry
In common: Parkinson's, cellular / molecular, 3 references
[10] doi:10.1007/s10565-026-10177-0
Multi-omics analysis and experimental validation reveal the IRF7-CXCL10 axis as a master regulator of microglial PCD in ischemic stroke.
Journal: Cell biology and toxicology
In common: cellular / molecular, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.